Global Travelers Vaccines Supply, Demand and Key Producers, 2026-2032
The global Travelers Vaccines market size is expected to reach $ 7814 million by 2032, rising at a market growth of 8.6% CAGR during the forecast period (2026-2032).
Travelers Vaccines refer to a range of preventive vaccines recommended or required for individuals traveling internationally for tourism, business, study, labor assignments, or humanitarian missions. These vaccines are designed to protect against infectious diseases prevalent in specific regions, such as yellow fever, typhoid fever, hepatitis A, hepatitis B, rabies, meningococcal disease, and cholera. Travelers vaccines include both routine immunization updates and destination-specific mandatory or recommended vaccinations, typically administered through specialized travel medicine clinics or international vaccination centers. Their core value lies in reducing cross-border transmission risks, safeguarding individual health, ensuring compliance with international entry regulations, and supporting global public health systems.In 2025, global Travelers Vaccine production reached approximately 780.18 million dosesand price is about 5.5 USD/dose.The average gross profit margin of this product is 70%.
The recovery of global cross-border mobility and the rebound of international tourism provide sustained growth momentum for the travelers vaccines market. Expanding business travel, overseas education, and labor mobility have made destination-specific health risk assessment an essential part of travel preparation. Strengthened public health controls and clearer vaccination certification requirements by destination countries further stimulate compliance-driven demand. Growing public health awareness and the emergence of premium outbound healthcare services are positioning travel medicine as an independent specialty segment. Improvements in digital appointment systems and vaccine cold chain infrastructure enhance accessibility and service efficiency.
Variations in vaccine approval and recommendation systems across countries complicate product registration and commercialization. Concerns about vaccine safety among certain traveler groups may affect uptake rates. Cold chain logistics and inventory management impose strict requirements on the supply chain, and improper handling may compromise product stability. Demand for certain vaccines is highly seasonal and region-specific, increasing forecasting complexity. In addition, global vaccine manufacturing capacity may be constrained by raw material availability and technological limitations, particularly during public health emergencies.
Downstream demand is concentrated in international travel clinics, entry-exit quarantine institutions, hospital immunization centers, and premium health screening facilities. Demand patterns are shifting from single mandatory vaccines to combination immunization programs, emphasizing personalized risk assessment and comprehensive health management. Long-term expatriates and high-risk occupational groups show increasing demand for booster doses and multi-dose vaccination schedules. Online health consultation and remote risk assessment services are becoming more prevalent, enabling earlier and more digitalized vaccination planning. Corporate group travel and international student populations represent important growth drivers.
The upstream segment of travelers vaccines includes key inputs such as antigen bulk materials, biological culture media, adjuvants, stabilizers, and packaging components. Vaccine production relies on high-standard bioreactor systems and aseptic filling technologies, with strict requirements for quality control and batch consistency. Cold chain equipment and temperature-controlled materials are essential to maintaining vaccine potency. As vaccine technologies advance toward recombinant proteins and combination formulations, the purity and complexity of upstream materials continue to increase. Supply chain stability and regulatory compliance capabilities are critical to ensuring continuous and reliable vaccine availability.
This report studies the global Travelers Vaccines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Travelers Vaccines and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Travelers Vaccines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Travelers Vaccines total production and demand, 2021-2032, (K Doses)
Global Travelers Vaccines total production value, 2021-2032, (USD Million)
Global Travelers Vaccines production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Doses), (based on production site)
Global Travelers Vaccines consumption by region & country, CAGR, 2021-2032 & (K Doses)
U.S. VS China: Travelers Vaccines domestic production, consumption, key domestic manufacturers and share
Global Travelers Vaccines production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Doses)
Global Travelers Vaccines production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Doses)
Global Travelers Vaccines production by End Users, production, value, CAGR, 2021-2032, (USD Million) & (K Doses)
This report profiles key players in the global Travelers Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Sanofi Pasteur, Merck, Pfizer, CNBG, Serum Institute, Biokangtai, NCPC, Dynavax, AIM Vaccine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Travelers Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (USD/Dose) by manufacturer, by Type, and by End Users. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Travelers Vaccines Market, By Region:
1. How big is the global Travelers Vaccines market?
2. What is the demand of the global Travelers Vaccines market?
3. What is the year over year growth of the global Travelers Vaccines market?
4. What is the production and production value of the global Travelers Vaccines market?
5. Who are the key producers in the global Travelers Vaccines market?
6. What are the growth factors driving the market demand?
Travelers Vaccines refer to a range of preventive vaccines recommended or required for individuals traveling internationally for tourism, business, study, labor assignments, or humanitarian missions. These vaccines are designed to protect against infectious diseases prevalent in specific regions, such as yellow fever, typhoid fever, hepatitis A, hepatitis B, rabies, meningococcal disease, and cholera. Travelers vaccines include both routine immunization updates and destination-specific mandatory or recommended vaccinations, typically administered through specialized travel medicine clinics or international vaccination centers. Their core value lies in reducing cross-border transmission risks, safeguarding individual health, ensuring compliance with international entry regulations, and supporting global public health systems.In 2025, global Travelers Vaccine production reached approximately 780.18 million dosesand price is about 5.5 USD/dose.The average gross profit margin of this product is 70%.
The recovery of global cross-border mobility and the rebound of international tourism provide sustained growth momentum for the travelers vaccines market. Expanding business travel, overseas education, and labor mobility have made destination-specific health risk assessment an essential part of travel preparation. Strengthened public health controls and clearer vaccination certification requirements by destination countries further stimulate compliance-driven demand. Growing public health awareness and the emergence of premium outbound healthcare services are positioning travel medicine as an independent specialty segment. Improvements in digital appointment systems and vaccine cold chain infrastructure enhance accessibility and service efficiency.
Variations in vaccine approval and recommendation systems across countries complicate product registration and commercialization. Concerns about vaccine safety among certain traveler groups may affect uptake rates. Cold chain logistics and inventory management impose strict requirements on the supply chain, and improper handling may compromise product stability. Demand for certain vaccines is highly seasonal and region-specific, increasing forecasting complexity. In addition, global vaccine manufacturing capacity may be constrained by raw material availability and technological limitations, particularly during public health emergencies.
Downstream demand is concentrated in international travel clinics, entry-exit quarantine institutions, hospital immunization centers, and premium health screening facilities. Demand patterns are shifting from single mandatory vaccines to combination immunization programs, emphasizing personalized risk assessment and comprehensive health management. Long-term expatriates and high-risk occupational groups show increasing demand for booster doses and multi-dose vaccination schedules. Online health consultation and remote risk assessment services are becoming more prevalent, enabling earlier and more digitalized vaccination planning. Corporate group travel and international student populations represent important growth drivers.
The upstream segment of travelers vaccines includes key inputs such as antigen bulk materials, biological culture media, adjuvants, stabilizers, and packaging components. Vaccine production relies on high-standard bioreactor systems and aseptic filling technologies, with strict requirements for quality control and batch consistency. Cold chain equipment and temperature-controlled materials are essential to maintaining vaccine potency. As vaccine technologies advance toward recombinant proteins and combination formulations, the purity and complexity of upstream materials continue to increase. Supply chain stability and regulatory compliance capabilities are critical to ensuring continuous and reliable vaccine availability.
This report studies the global Travelers Vaccines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Travelers Vaccines and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Travelers Vaccines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Travelers Vaccines total production and demand, 2021-2032, (K Doses)
Global Travelers Vaccines total production value, 2021-2032, (USD Million)
Global Travelers Vaccines production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Doses), (based on production site)
Global Travelers Vaccines consumption by region & country, CAGR, 2021-2032 & (K Doses)
U.S. VS China: Travelers Vaccines domestic production, consumption, key domestic manufacturers and share
Global Travelers Vaccines production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Doses)
Global Travelers Vaccines production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Doses)
Global Travelers Vaccines production by End Users, production, value, CAGR, 2021-2032, (USD Million) & (K Doses)
This report profiles key players in the global Travelers Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Sanofi Pasteur, Merck, Pfizer, CNBG, Serum Institute, Biokangtai, NCPC, Dynavax, AIM Vaccine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Travelers Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (USD/Dose) by manufacturer, by Type, and by End Users. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Travelers Vaccines Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Meningococcal Vaccine
- Japanese Encephalitis Vaccine
- Yellow Fever Vaccine
- Hepatitis Vaccine
- Cholera Vaccine
- Other
- Mandatory Vaccination
- Recommended Vaccination
- Routine Booster
- Travel Clinics
- Public Hospitals
- Private Providers
- Tourists
- Students
- Workers
- Others
- GSK
- Sanofi Pasteur
- Merck
- Pfizer
- CNBG
- Serum Institute
- Biokangtai
- NCPC
- Dynavax
- AIM Vaccine
- KM Biologics
- LG Life Sciences
1. How big is the global Travelers Vaccines market?
2. What is the demand of the global Travelers Vaccines market?
3. What is the year over year growth of the global Travelers Vaccines market?
4. What is the production and production value of the global Travelers Vaccines market?
5. Who are the key producers in the global Travelers Vaccines market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Travelers Vaccines Introduction
1.2 World Travelers Vaccines Supply & Forecast
1.2.1 World Travelers Vaccines Production Value (2021 & 2025 & 2032)
1.2.2 World Travelers Vaccines Production (2021-2032)
1.2.3 World Travelers Vaccines Pricing Trends (2021-2032)
1.3 World Travelers Vaccines Production by Region (Based on Production Site)
1.3.1 World Travelers Vaccines Production Value by Region (2021-2032)
1.3.2 World Travelers Vaccines Production by Region (2021-2032)
1.3.3 World Travelers Vaccines Average Price by Region (2021-2032)
1.3.4 North America Travelers Vaccines Production (2021-2032)
1.3.5 Europe Travelers Vaccines Production (2021-2032)
1.3.6 China Travelers Vaccines Production (2021-2032)
1.3.7 Japan Travelers Vaccines Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Travelers Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Travelers Vaccines Major Market Trends
2 DEMAND SUMMARY
2.1 World Travelers Vaccines Demand (2021-2032)
2.2 World Travelers Vaccines Consumption by Region
2.2.1 World Travelers Vaccines Consumption by Region (2021-2026)
2.2.2 World Travelers Vaccines Consumption Forecast by Region (2027-2032)
2.3 United States Travelers Vaccines Consumption (2021-2032)
2.4 China Travelers Vaccines Consumption (2021-2032)
2.5 Europe Travelers Vaccines Consumption (2021-2032)
2.6 Japan Travelers Vaccines Consumption (2021-2032)
2.7 South Korea Travelers Vaccines Consumption (2021-2032)
2.8 ASEAN Travelers Vaccines Consumption (2021-2032)
2.9 India Travelers Vaccines Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Travelers Vaccines Production Value by Manufacturer (2021-2026)
3.2 World Travelers Vaccines Production by Manufacturer (2021-2026)
3.3 World Travelers Vaccines Average Price by Manufacturer (2021-2026)
3.4 Travelers Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Travelers Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Travelers Vaccines in 2025
3.5.3 Global Concentration Ratios (CR8) for Travelers Vaccines in 2025
3.6 Travelers Vaccines Market: Overall Company Footprint Analysis
3.6.1 Travelers Vaccines Market: Region Footprint
3.6.2 Travelers Vaccines Market: Company Product Type Footprint
3.6.3 Travelers Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Travelers Vaccines Production Value Comparison
4.1.1 United States VS China: Travelers Vaccines Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Travelers Vaccines Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Travelers Vaccines Production Comparison
4.2.1 United States VS China: Travelers Vaccines Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Travelers Vaccines Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Travelers Vaccines Consumption Comparison
4.3.1 United States VS China: Travelers Vaccines Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Travelers Vaccines Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Travelers Vaccines Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Travelers Vaccines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Travelers Vaccines Production Value (2021-2026)
4.4.3 United States Based Manufacturers Travelers Vaccines Production (2021-2026)
4.5 China Based Travelers Vaccines Manufacturers and Market Share
4.5.1 China Based Travelers Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Travelers Vaccines Production Value (2021-2026)
4.5.3 China Based Manufacturers Travelers Vaccines Production (2021-2026)
4.6 Rest of World Based Travelers Vaccines Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Travelers Vaccines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Travelers Vaccines Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Travelers Vaccines Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Travelers Vaccines Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Meningococcal Vaccine
5.2.2 Japanese Encephalitis Vaccine
5.2.3 Yellow Fever Vaccine
5.2.4 Hepatitis Vaccine
5.2.5 Cholera Vaccine
5.2.6 Other
5.3 Market Segment by Type
5.3.1 World Travelers Vaccines Production by Type (2021-2032)
5.3.2 World Travelers Vaccines Production Value by Type (2021-2032)
5.3.3 World Travelers Vaccines Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY VACCINATION PURPOSE
6.1 World Travelers Vaccines Market Size Overview by Vaccination Purpose: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Vaccination Purpose
6.2.1 Mandatory Vaccination
6.2.2 Recommended Vaccination
6.2.3 Routine Booster
6.3 Market Segment by Vaccination Purpose
6.3.1 World Travelers Vaccines Production by Vaccination Purpose (2021-2032)
6.3.2 World Travelers Vaccines Production Value by Vaccination Purpose (2021-2032)
6.3.3 World Travelers Vaccines Average Price by Vaccination Purpose (2021-2032)
7 MARKET ANALYSIS BY END CHANNEL
7.1 World Travelers Vaccines Market Size Overview by End Channel: 2021 VS 2025 VS 2032
7.2 Segment Introduction by End Channel
7.2.1 Travel Clinics
7.2.2 Public Hospitals
7.2.3 Private Providers
7.3 Market Segment by End Channel
7.3.1 World Travelers Vaccines Production by End Channel (2021-2032)
7.3.2 World Travelers Vaccines Production Value by End Channel (2021-2032)
7.3.3 World Travelers Vaccines Average Price by End Channel (2021-2032)
8 MARKET ANALYSIS BY END USERS
8.1 World Travelers Vaccines Market Size Overview by End Users: 2021 VS 2025 VS 2032
8.2 Segment Introduction by End Users
8.2.1 Tourists
8.2.2 Students
8.2.3 Workers
8.2.4 Others
8.3 Market Segment by End Users
8.3.1 World Travelers Vaccines Production by End Users (2021-2032)
8.3.2 World Travelers Vaccines Production Value by End Users (2021-2032)
8.3.3 World Travelers Vaccines Average Price by End Users (2021-2032)
9 COMPANY PROFILES
9.1 GSK
9.1.1 GSK Details
9.1.2 GSK Major Business
9.1.3 GSK Travelers Vaccines Product and Services
9.1.4 GSK Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 GSK Recent Developments/Updates
9.1.6 GSK Competitive Strengths & Weaknesses
9.2 Sanofi Pasteur
9.2.1 Sanofi Pasteur Details
9.2.2 Sanofi Pasteur Major Business
9.2.3 Sanofi Pasteur Travelers Vaccines Product and Services
9.2.4 Sanofi Pasteur Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Sanofi Pasteur Recent Developments/Updates
9.2.6 Sanofi Pasteur Competitive Strengths & Weaknesses
9.3 Merck
9.3.1 Merck Details
9.3.2 Merck Major Business
9.3.3 Merck Travelers Vaccines Product and Services
9.3.4 Merck Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Merck Recent Developments/Updates
9.3.6 Merck Competitive Strengths & Weaknesses
9.4 Pfizer
9.4.1 Pfizer Details
9.4.2 Pfizer Major Business
9.4.3 Pfizer Travelers Vaccines Product and Services
9.4.4 Pfizer Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Pfizer Recent Developments/Updates
9.4.6 Pfizer Competitive Strengths & Weaknesses
9.5 CNBG
9.5.1 CNBG Details
9.5.2 CNBG Major Business
9.5.3 CNBG Travelers Vaccines Product and Services
9.5.4 CNBG Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 CNBG Recent Developments/Updates
9.5.6 CNBG Competitive Strengths & Weaknesses
9.6 Serum Institute
9.6.1 Serum Institute Details
9.6.2 Serum Institute Major Business
9.6.3 Serum Institute Travelers Vaccines Product and Services
9.6.4 Serum Institute Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Serum Institute Recent Developments/Updates
9.6.6 Serum Institute Competitive Strengths & Weaknesses
9.7 Biokangtai
9.7.1 Biokangtai Details
9.7.2 Biokangtai Major Business
9.7.3 Biokangtai Travelers Vaccines Product and Services
9.7.4 Biokangtai Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Biokangtai Recent Developments/Updates
9.7.6 Biokangtai Competitive Strengths & Weaknesses
9.8 NCPC
9.8.1 NCPC Details
9.8.2 NCPC Major Business
9.8.3 NCPC Travelers Vaccines Product and Services
9.8.4 NCPC Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 NCPC Recent Developments/Updates
9.8.6 NCPC Competitive Strengths & Weaknesses
9.9 Dynavax
9.9.1 Dynavax Details
9.9.2 Dynavax Major Business
9.9.3 Dynavax Travelers Vaccines Product and Services
9.9.4 Dynavax Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Dynavax Recent Developments/Updates
9.9.6 Dynavax Competitive Strengths & Weaknesses
9.10 AIM Vaccine
9.10.1 AIM Vaccine Details
9.10.2 AIM Vaccine Major Business
9.10.3 AIM Vaccine Travelers Vaccines Product and Services
9.10.4 AIM Vaccine Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 AIM Vaccine Recent Developments/Updates
9.10.6 AIM Vaccine Competitive Strengths & Weaknesses
9.11 KM Biologics
9.11.1 KM Biologics Details
9.11.2 KM Biologics Major Business
9.11.3 KM Biologics Travelers Vaccines Product and Services
9.11.4 KM Biologics Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 KM Biologics Recent Developments/Updates
9.11.6 KM Biologics Competitive Strengths & Weaknesses
9.12 LG Life Sciences
9.12.1 LG Life Sciences Details
9.12.2 LG Life Sciences Major Business
9.12.3 LG Life Sciences Travelers Vaccines Product and Services
9.12.4 LG Life Sciences Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 LG Life Sciences Recent Developments/Updates
9.12.6 LG Life Sciences Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Travelers Vaccines Industry Chain
10.2 Travelers Vaccines Upstream Analysis
10.2.1 Travelers Vaccines Core Raw Materials
10.2.2 Main Manufacturers of Travelers Vaccines Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Travelers Vaccines Production Mode
10.6 Travelers Vaccines Procurement Model
10.7 Travelers Vaccines Industry Sales Model and Sales Channels
10.7.1 Travelers Vaccines Sales Model
10.7.2 Travelers Vaccines Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Travelers Vaccines Introduction
1.2 World Travelers Vaccines Supply & Forecast
1.2.1 World Travelers Vaccines Production Value (2021 & 2025 & 2032)
1.2.2 World Travelers Vaccines Production (2021-2032)
1.2.3 World Travelers Vaccines Pricing Trends (2021-2032)
1.3 World Travelers Vaccines Production by Region (Based on Production Site)
1.3.1 World Travelers Vaccines Production Value by Region (2021-2032)
1.3.2 World Travelers Vaccines Production by Region (2021-2032)
1.3.3 World Travelers Vaccines Average Price by Region (2021-2032)
1.3.4 North America Travelers Vaccines Production (2021-2032)
1.3.5 Europe Travelers Vaccines Production (2021-2032)
1.3.6 China Travelers Vaccines Production (2021-2032)
1.3.7 Japan Travelers Vaccines Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Travelers Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Travelers Vaccines Major Market Trends
2 DEMAND SUMMARY
2.1 World Travelers Vaccines Demand (2021-2032)
2.2 World Travelers Vaccines Consumption by Region
2.2.1 World Travelers Vaccines Consumption by Region (2021-2026)
2.2.2 World Travelers Vaccines Consumption Forecast by Region (2027-2032)
2.3 United States Travelers Vaccines Consumption (2021-2032)
2.4 China Travelers Vaccines Consumption (2021-2032)
2.5 Europe Travelers Vaccines Consumption (2021-2032)
2.6 Japan Travelers Vaccines Consumption (2021-2032)
2.7 South Korea Travelers Vaccines Consumption (2021-2032)
2.8 ASEAN Travelers Vaccines Consumption (2021-2032)
2.9 India Travelers Vaccines Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Travelers Vaccines Production Value by Manufacturer (2021-2026)
3.2 World Travelers Vaccines Production by Manufacturer (2021-2026)
3.3 World Travelers Vaccines Average Price by Manufacturer (2021-2026)
3.4 Travelers Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Travelers Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Travelers Vaccines in 2025
3.5.3 Global Concentration Ratios (CR8) for Travelers Vaccines in 2025
3.6 Travelers Vaccines Market: Overall Company Footprint Analysis
3.6.1 Travelers Vaccines Market: Region Footprint
3.6.2 Travelers Vaccines Market: Company Product Type Footprint
3.6.3 Travelers Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Travelers Vaccines Production Value Comparison
4.1.1 United States VS China: Travelers Vaccines Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Travelers Vaccines Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Travelers Vaccines Production Comparison
4.2.1 United States VS China: Travelers Vaccines Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Travelers Vaccines Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Travelers Vaccines Consumption Comparison
4.3.1 United States VS China: Travelers Vaccines Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Travelers Vaccines Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Travelers Vaccines Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Travelers Vaccines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Travelers Vaccines Production Value (2021-2026)
4.4.3 United States Based Manufacturers Travelers Vaccines Production (2021-2026)
4.5 China Based Travelers Vaccines Manufacturers and Market Share
4.5.1 China Based Travelers Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Travelers Vaccines Production Value (2021-2026)
4.5.3 China Based Manufacturers Travelers Vaccines Production (2021-2026)
4.6 Rest of World Based Travelers Vaccines Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Travelers Vaccines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Travelers Vaccines Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Travelers Vaccines Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Travelers Vaccines Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Meningococcal Vaccine
5.2.2 Japanese Encephalitis Vaccine
5.2.3 Yellow Fever Vaccine
5.2.4 Hepatitis Vaccine
5.2.5 Cholera Vaccine
5.2.6 Other
5.3 Market Segment by Type
5.3.1 World Travelers Vaccines Production by Type (2021-2032)
5.3.2 World Travelers Vaccines Production Value by Type (2021-2032)
5.3.3 World Travelers Vaccines Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY VACCINATION PURPOSE
6.1 World Travelers Vaccines Market Size Overview by Vaccination Purpose: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Vaccination Purpose
6.2.1 Mandatory Vaccination
6.2.2 Recommended Vaccination
6.2.3 Routine Booster
6.3 Market Segment by Vaccination Purpose
6.3.1 World Travelers Vaccines Production by Vaccination Purpose (2021-2032)
6.3.2 World Travelers Vaccines Production Value by Vaccination Purpose (2021-2032)
6.3.3 World Travelers Vaccines Average Price by Vaccination Purpose (2021-2032)
7 MARKET ANALYSIS BY END CHANNEL
7.1 World Travelers Vaccines Market Size Overview by End Channel: 2021 VS 2025 VS 2032
7.2 Segment Introduction by End Channel
7.2.1 Travel Clinics
7.2.2 Public Hospitals
7.2.3 Private Providers
7.3 Market Segment by End Channel
7.3.1 World Travelers Vaccines Production by End Channel (2021-2032)
7.3.2 World Travelers Vaccines Production Value by End Channel (2021-2032)
7.3.3 World Travelers Vaccines Average Price by End Channel (2021-2032)
8 MARKET ANALYSIS BY END USERS
8.1 World Travelers Vaccines Market Size Overview by End Users: 2021 VS 2025 VS 2032
8.2 Segment Introduction by End Users
8.2.1 Tourists
8.2.2 Students
8.2.3 Workers
8.2.4 Others
8.3 Market Segment by End Users
8.3.1 World Travelers Vaccines Production by End Users (2021-2032)
8.3.2 World Travelers Vaccines Production Value by End Users (2021-2032)
8.3.3 World Travelers Vaccines Average Price by End Users (2021-2032)
9 COMPANY PROFILES
9.1 GSK
9.1.1 GSK Details
9.1.2 GSK Major Business
9.1.3 GSK Travelers Vaccines Product and Services
9.1.4 GSK Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 GSK Recent Developments/Updates
9.1.6 GSK Competitive Strengths & Weaknesses
9.2 Sanofi Pasteur
9.2.1 Sanofi Pasteur Details
9.2.2 Sanofi Pasteur Major Business
9.2.3 Sanofi Pasteur Travelers Vaccines Product and Services
9.2.4 Sanofi Pasteur Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Sanofi Pasteur Recent Developments/Updates
9.2.6 Sanofi Pasteur Competitive Strengths & Weaknesses
9.3 Merck
9.3.1 Merck Details
9.3.2 Merck Major Business
9.3.3 Merck Travelers Vaccines Product and Services
9.3.4 Merck Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Merck Recent Developments/Updates
9.3.6 Merck Competitive Strengths & Weaknesses
9.4 Pfizer
9.4.1 Pfizer Details
9.4.2 Pfizer Major Business
9.4.3 Pfizer Travelers Vaccines Product and Services
9.4.4 Pfizer Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Pfizer Recent Developments/Updates
9.4.6 Pfizer Competitive Strengths & Weaknesses
9.5 CNBG
9.5.1 CNBG Details
9.5.2 CNBG Major Business
9.5.3 CNBG Travelers Vaccines Product and Services
9.5.4 CNBG Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 CNBG Recent Developments/Updates
9.5.6 CNBG Competitive Strengths & Weaknesses
9.6 Serum Institute
9.6.1 Serum Institute Details
9.6.2 Serum Institute Major Business
9.6.3 Serum Institute Travelers Vaccines Product and Services
9.6.4 Serum Institute Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Serum Institute Recent Developments/Updates
9.6.6 Serum Institute Competitive Strengths & Weaknesses
9.7 Biokangtai
9.7.1 Biokangtai Details
9.7.2 Biokangtai Major Business
9.7.3 Biokangtai Travelers Vaccines Product and Services
9.7.4 Biokangtai Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Biokangtai Recent Developments/Updates
9.7.6 Biokangtai Competitive Strengths & Weaknesses
9.8 NCPC
9.8.1 NCPC Details
9.8.2 NCPC Major Business
9.8.3 NCPC Travelers Vaccines Product and Services
9.8.4 NCPC Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 NCPC Recent Developments/Updates
9.8.6 NCPC Competitive Strengths & Weaknesses
9.9 Dynavax
9.9.1 Dynavax Details
9.9.2 Dynavax Major Business
9.9.3 Dynavax Travelers Vaccines Product and Services
9.9.4 Dynavax Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Dynavax Recent Developments/Updates
9.9.6 Dynavax Competitive Strengths & Weaknesses
9.10 AIM Vaccine
9.10.1 AIM Vaccine Details
9.10.2 AIM Vaccine Major Business
9.10.3 AIM Vaccine Travelers Vaccines Product and Services
9.10.4 AIM Vaccine Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 AIM Vaccine Recent Developments/Updates
9.10.6 AIM Vaccine Competitive Strengths & Weaknesses
9.11 KM Biologics
9.11.1 KM Biologics Details
9.11.2 KM Biologics Major Business
9.11.3 KM Biologics Travelers Vaccines Product and Services
9.11.4 KM Biologics Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 KM Biologics Recent Developments/Updates
9.11.6 KM Biologics Competitive Strengths & Weaknesses
9.12 LG Life Sciences
9.12.1 LG Life Sciences Details
9.12.2 LG Life Sciences Major Business
9.12.3 LG Life Sciences Travelers Vaccines Product and Services
9.12.4 LG Life Sciences Travelers Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 LG Life Sciences Recent Developments/Updates
9.12.6 LG Life Sciences Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Travelers Vaccines Industry Chain
10.2 Travelers Vaccines Upstream Analysis
10.2.1 Travelers Vaccines Core Raw Materials
10.2.2 Main Manufacturers of Travelers Vaccines Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Travelers Vaccines Production Mode
10.6 Travelers Vaccines Procurement Model
10.7 Travelers Vaccines Industry Sales Model and Sales Channels
10.7.1 Travelers Vaccines Sales Model
10.7.2 Travelers Vaccines Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Travelers Vaccines Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Travelers Vaccines Production Value by Region (2021-2026) & (USD Million)
Table 3. World Travelers Vaccines Production Value by Region (2027-2032) & (USD Million)
Table 4. World Travelers Vaccines Production Value Market Share by Region (2021-2026)
Table 5. World Travelers Vaccines Production Value Market Share by Region (2027-2032)
Table 6. World Travelers Vaccines Production by Region (2021-2026) & (K Doses)
Table 7. World Travelers Vaccines Production by Region (2027-2032) & (K Doses)
Table 8. World Travelers Vaccines Production Market Share by Region (2021-2026)
Table 9. World Travelers Vaccines Production Market Share by Region (2027-2032)
Table 10. World Travelers Vaccines Average Price by Region (2021-2026) & (USD/Dose)
Table 11. World Travelers Vaccines Average Price by Region (2027-2032) & (USD/Dose)
Table 12. Travelers Vaccines Major Market Trends
Table 13. World Travelers Vaccines Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Doses)
Table 14. World Travelers Vaccines Consumption by Region (2021-2026) & (K Doses)
Table 15. World Travelers Vaccines Consumption Forecast by Region (2027-2032) & (K Doses)
Table 16. World Travelers Vaccines Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Travelers Vaccines Producers in 2025
Table 18. World Travelers Vaccines Production by Manufacturer (2021-2026) & (K Doses)
Table 19. Production Market Share of Key Travelers Vaccines Producers in 2025
Table 20. World Travelers Vaccines Average Price by Manufacturer (2021-2026) & (USD/Dose)
Table 21. Global Travelers Vaccines Company Evaluation Quadrant
Table 22. World Travelers Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Travelers Vaccines Production Site of Key Manufacturer
Table 24. Travelers Vaccines Market: Company Product Type Footprint
Table 25. Travelers Vaccines Market: Company Product Application Footprint
Table 26. Travelers Vaccines Competitive Factors
Table 27. Travelers Vaccines New Entrant and Capacity Expansion Plans
Table 28. Travelers Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China Travelers Vaccines Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Travelers Vaccines Production Comparison, (2021 & 2025 & 2032) & (K Doses)
Table 31. United States VS China Travelers Vaccines Consumption Comparison, (2021 & 2025 & 2032) & (K Doses)
Table 32. United States Based Travelers Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Travelers Vaccines Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Travelers Vaccines Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Travelers Vaccines Production (2021-2026) & (K Doses)
Table 36. United States Based Manufacturers Travelers Vaccines Production Market Share (2021-2026)
Table 37. China Based Travelers Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Travelers Vaccines Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Travelers Vaccines Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Travelers Vaccines Production, (2021-2026) & (K Doses)
Table 41. China Based Manufacturers Travelers Vaccines Production Market Share (2021-2026)
Table 42. Rest of World Based Travelers Vaccines Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Travelers Vaccines Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Travelers Vaccines Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Travelers Vaccines Production, (2021-2026) & (K Doses)
Table 46. Rest of World Based Manufacturers Travelers Vaccines Production Market Share (2021-2026)
Table 47. World Travelers Vaccines Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Travelers Vaccines Production by Type (2021-2026) & (K Doses)
Table 49. World Travelers Vaccines Production by Type (2027-2032) & (K Doses)
Table 50. World Travelers Vaccines Production Value by Type (2021-2026) & (USD Million)
Table 51. World Travelers Vaccines Production Value by Type (2027-2032) & (USD Million)
Table 52. World Travelers Vaccines Average Price by Type (2021-2026) & (USD/Dose)
Table 53. World Travelers Vaccines Average Price by Type (2027-2032) & (USD/Dose)
Table 54. World Travelers Vaccines Production Value by Vaccination Purpose, (USD Million), 2021 & 2025 & 2032
Table 55. World Travelers Vaccines Production by Vaccination Purpose (2021-2026) & (K Doses)
Table 56. World Travelers Vaccines Production by Vaccination Purpose (2027-2032) & (K Doses)
Table 57. World Travelers Vaccines Production Value by Vaccination Purpose (2021-2026) & (USD Million)
Table 58. World Travelers Vaccines Production Value by Vaccination Purpose (2027-2032) & (USD Million)
Table 59. World Travelers Vaccines Average Price by Vaccination Purpose (2021-2026) & (USD/Dose)
Table 60. World Travelers Vaccines Average Price by Vaccination Purpose (2027-2032) & (USD/Dose)
Table 61. World Travelers Vaccines Production Value by End Channel, (USD Million), 2021 & 2025 & 2032
Table 62. World Travelers Vaccines Production by End Channel (2021-2026) & (K Doses)
Table 63. World Travelers Vaccines Production by End Channel (2027-2032) & (K Doses)
Table 64. World Travelers Vaccines Production Value by End Channel (2021-2026) & (USD Million)
Table 65. World Travelers Vaccines Production Value by End Channel (2027-2032) & (USD Million)
Table 66. World Travelers Vaccines Average Price by End Channel (2021-2026) & (USD/Dose)
Table 67. World Travelers Vaccines Average Price by End Channel (2027-2032) & (USD/Dose)
Table 68. World Travelers Vaccines Production Value by End Users, (USD Million), 2021 & 2025 & 2032
Table 69. World Travelers Vaccines Production by End Users (2021-2026) & (K Doses)
Table 70. World Travelers Vaccines Production by End Users (2027-2032) & (K Doses)
Table 71. World Travelers Vaccines Production Value by End Users (2021-2026) & (USD Million)
Table 72. World Travelers Vaccines Production Value by End Users (2027-2032) & (USD Million)
Table 73. World Travelers Vaccines Average Price by End Users (2021-2026) & (USD/Dose)
Table 74. World Travelers Vaccines Average Price by End Users (2027-2032) & (USD/Dose)
Table 75. GSK Basic Information, Manufacturing Base and Competitors
Table 76. GSK Major Business
Table 77. GSK Travelers Vaccines Product and Services
Table 78. GSK Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. GSK Recent Developments/Updates
Table 80. GSK Competitive Strengths & Weaknesses
Table 81. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 82. Sanofi Pasteur Major Business
Table 83. Sanofi Pasteur Travelers Vaccines Product and Services
Table 84. Sanofi Pasteur Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Sanofi Pasteur Recent Developments/Updates
Table 86. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 87. Merck Basic Information, Manufacturing Base and Competitors
Table 88. Merck Major Business
Table 89. Merck Travelers Vaccines Product and Services
Table 90. Merck Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Merck Recent Developments/Updates
Table 92. Merck Competitive Strengths & Weaknesses
Table 93. Pfizer Basic Information, Manufacturing Base and Competitors
Table 94. Pfizer Major Business
Table 95. Pfizer Travelers Vaccines Product and Services
Table 96. Pfizer Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Pfizer Recent Developments/Updates
Table 98. Pfizer Competitive Strengths & Weaknesses
Table 99. CNBG Basic Information, Manufacturing Base and Competitors
Table 100. CNBG Major Business
Table 101. CNBG Travelers Vaccines Product and Services
Table 102. CNBG Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. CNBG Recent Developments/Updates
Table 104. CNBG Competitive Strengths & Weaknesses
Table 105. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 106. Serum Institute Major Business
Table 107. Serum Institute Travelers Vaccines Product and Services
Table 108. Serum Institute Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Serum Institute Recent Developments/Updates
Table 110. Serum Institute Competitive Strengths & Weaknesses
Table 111. Biokangtai Basic Information, Manufacturing Base and Competitors
Table 112. Biokangtai Major Business
Table 113. Biokangtai Travelers Vaccines Product and Services
Table 114. Biokangtai Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Biokangtai Recent Developments/Updates
Table 116. Biokangtai Competitive Strengths & Weaknesses
Table 117. NCPC Basic Information, Manufacturing Base and Competitors
Table 118. NCPC Major Business
Table 119. NCPC Travelers Vaccines Product and Services
Table 120. NCPC Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. NCPC Recent Developments/Updates
Table 122. NCPC Competitive Strengths & Weaknesses
Table 123. Dynavax Basic Information, Manufacturing Base and Competitors
Table 124. Dynavax Major Business
Table 125. Dynavax Travelers Vaccines Product and Services
Table 126. Dynavax Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Dynavax Recent Developments/Updates
Table 128. Dynavax Competitive Strengths & Weaknesses
Table 129. AIM Vaccine Basic Information, Manufacturing Base and Competitors
Table 130. AIM Vaccine Major Business
Table 131. AIM Vaccine Travelers Vaccines Product and Services
Table 132. AIM Vaccine Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. AIM Vaccine Recent Developments/Updates
Table 134. AIM Vaccine Competitive Strengths & Weaknesses
Table 135. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 136. KM Biologics Major Business
Table 137. KM Biologics Travelers Vaccines Product and Services
Table 138. KM Biologics Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. KM Biologics Recent Developments/Updates
Table 140. KM Biologics Competitive Strengths & Weaknesses
Table 141. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 142. LG Life Sciences Major Business
Table 143. LG Life Sciences Travelers Vaccines Product and Services
Table 144. LG Life Sciences Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. LG Life Sciences Recent Developments/Updates
Table 146. LG Life Sciences Competitive Strengths & Weaknesses
Table 147. Global Key Players of Travelers Vaccines Upstream (Raw Materials)
Table 148. Global Travelers Vaccines Typical Customers
Table 149. Travelers Vaccines Typical Distributors
Table 1. World Travelers Vaccines Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Travelers Vaccines Production Value by Region (2021-2026) & (USD Million)
Table 3. World Travelers Vaccines Production Value by Region (2027-2032) & (USD Million)
Table 4. World Travelers Vaccines Production Value Market Share by Region (2021-2026)
Table 5. World Travelers Vaccines Production Value Market Share by Region (2027-2032)
Table 6. World Travelers Vaccines Production by Region (2021-2026) & (K Doses)
Table 7. World Travelers Vaccines Production by Region (2027-2032) & (K Doses)
Table 8. World Travelers Vaccines Production Market Share by Region (2021-2026)
Table 9. World Travelers Vaccines Production Market Share by Region (2027-2032)
Table 10. World Travelers Vaccines Average Price by Region (2021-2026) & (USD/Dose)
Table 11. World Travelers Vaccines Average Price by Region (2027-2032) & (USD/Dose)
Table 12. Travelers Vaccines Major Market Trends
Table 13. World Travelers Vaccines Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Doses)
Table 14. World Travelers Vaccines Consumption by Region (2021-2026) & (K Doses)
Table 15. World Travelers Vaccines Consumption Forecast by Region (2027-2032) & (K Doses)
Table 16. World Travelers Vaccines Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Travelers Vaccines Producers in 2025
Table 18. World Travelers Vaccines Production by Manufacturer (2021-2026) & (K Doses)
Table 19. Production Market Share of Key Travelers Vaccines Producers in 2025
Table 20. World Travelers Vaccines Average Price by Manufacturer (2021-2026) & (USD/Dose)
Table 21. Global Travelers Vaccines Company Evaluation Quadrant
Table 22. World Travelers Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Travelers Vaccines Production Site of Key Manufacturer
Table 24. Travelers Vaccines Market: Company Product Type Footprint
Table 25. Travelers Vaccines Market: Company Product Application Footprint
Table 26. Travelers Vaccines Competitive Factors
Table 27. Travelers Vaccines New Entrant and Capacity Expansion Plans
Table 28. Travelers Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China Travelers Vaccines Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Travelers Vaccines Production Comparison, (2021 & 2025 & 2032) & (K Doses)
Table 31. United States VS China Travelers Vaccines Consumption Comparison, (2021 & 2025 & 2032) & (K Doses)
Table 32. United States Based Travelers Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Travelers Vaccines Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Travelers Vaccines Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Travelers Vaccines Production (2021-2026) & (K Doses)
Table 36. United States Based Manufacturers Travelers Vaccines Production Market Share (2021-2026)
Table 37. China Based Travelers Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Travelers Vaccines Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Travelers Vaccines Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Travelers Vaccines Production, (2021-2026) & (K Doses)
Table 41. China Based Manufacturers Travelers Vaccines Production Market Share (2021-2026)
Table 42. Rest of World Based Travelers Vaccines Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Travelers Vaccines Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Travelers Vaccines Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Travelers Vaccines Production, (2021-2026) & (K Doses)
Table 46. Rest of World Based Manufacturers Travelers Vaccines Production Market Share (2021-2026)
Table 47. World Travelers Vaccines Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Travelers Vaccines Production by Type (2021-2026) & (K Doses)
Table 49. World Travelers Vaccines Production by Type (2027-2032) & (K Doses)
Table 50. World Travelers Vaccines Production Value by Type (2021-2026) & (USD Million)
Table 51. World Travelers Vaccines Production Value by Type (2027-2032) & (USD Million)
Table 52. World Travelers Vaccines Average Price by Type (2021-2026) & (USD/Dose)
Table 53. World Travelers Vaccines Average Price by Type (2027-2032) & (USD/Dose)
Table 54. World Travelers Vaccines Production Value by Vaccination Purpose, (USD Million), 2021 & 2025 & 2032
Table 55. World Travelers Vaccines Production by Vaccination Purpose (2021-2026) & (K Doses)
Table 56. World Travelers Vaccines Production by Vaccination Purpose (2027-2032) & (K Doses)
Table 57. World Travelers Vaccines Production Value by Vaccination Purpose (2021-2026) & (USD Million)
Table 58. World Travelers Vaccines Production Value by Vaccination Purpose (2027-2032) & (USD Million)
Table 59. World Travelers Vaccines Average Price by Vaccination Purpose (2021-2026) & (USD/Dose)
Table 60. World Travelers Vaccines Average Price by Vaccination Purpose (2027-2032) & (USD/Dose)
Table 61. World Travelers Vaccines Production Value by End Channel, (USD Million), 2021 & 2025 & 2032
Table 62. World Travelers Vaccines Production by End Channel (2021-2026) & (K Doses)
Table 63. World Travelers Vaccines Production by End Channel (2027-2032) & (K Doses)
Table 64. World Travelers Vaccines Production Value by End Channel (2021-2026) & (USD Million)
Table 65. World Travelers Vaccines Production Value by End Channel (2027-2032) & (USD Million)
Table 66. World Travelers Vaccines Average Price by End Channel (2021-2026) & (USD/Dose)
Table 67. World Travelers Vaccines Average Price by End Channel (2027-2032) & (USD/Dose)
Table 68. World Travelers Vaccines Production Value by End Users, (USD Million), 2021 & 2025 & 2032
Table 69. World Travelers Vaccines Production by End Users (2021-2026) & (K Doses)
Table 70. World Travelers Vaccines Production by End Users (2027-2032) & (K Doses)
Table 71. World Travelers Vaccines Production Value by End Users (2021-2026) & (USD Million)
Table 72. World Travelers Vaccines Production Value by End Users (2027-2032) & (USD Million)
Table 73. World Travelers Vaccines Average Price by End Users (2021-2026) & (USD/Dose)
Table 74. World Travelers Vaccines Average Price by End Users (2027-2032) & (USD/Dose)
Table 75. GSK Basic Information, Manufacturing Base and Competitors
Table 76. GSK Major Business
Table 77. GSK Travelers Vaccines Product and Services
Table 78. GSK Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. GSK Recent Developments/Updates
Table 80. GSK Competitive Strengths & Weaknesses
Table 81. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 82. Sanofi Pasteur Major Business
Table 83. Sanofi Pasteur Travelers Vaccines Product and Services
Table 84. Sanofi Pasteur Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Sanofi Pasteur Recent Developments/Updates
Table 86. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 87. Merck Basic Information, Manufacturing Base and Competitors
Table 88. Merck Major Business
Table 89. Merck Travelers Vaccines Product and Services
Table 90. Merck Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Merck Recent Developments/Updates
Table 92. Merck Competitive Strengths & Weaknesses
Table 93. Pfizer Basic Information, Manufacturing Base and Competitors
Table 94. Pfizer Major Business
Table 95. Pfizer Travelers Vaccines Product and Services
Table 96. Pfizer Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Pfizer Recent Developments/Updates
Table 98. Pfizer Competitive Strengths & Weaknesses
Table 99. CNBG Basic Information, Manufacturing Base and Competitors
Table 100. CNBG Major Business
Table 101. CNBG Travelers Vaccines Product and Services
Table 102. CNBG Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. CNBG Recent Developments/Updates
Table 104. CNBG Competitive Strengths & Weaknesses
Table 105. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 106. Serum Institute Major Business
Table 107. Serum Institute Travelers Vaccines Product and Services
Table 108. Serum Institute Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Serum Institute Recent Developments/Updates
Table 110. Serum Institute Competitive Strengths & Weaknesses
Table 111. Biokangtai Basic Information, Manufacturing Base and Competitors
Table 112. Biokangtai Major Business
Table 113. Biokangtai Travelers Vaccines Product and Services
Table 114. Biokangtai Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Biokangtai Recent Developments/Updates
Table 116. Biokangtai Competitive Strengths & Weaknesses
Table 117. NCPC Basic Information, Manufacturing Base and Competitors
Table 118. NCPC Major Business
Table 119. NCPC Travelers Vaccines Product and Services
Table 120. NCPC Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. NCPC Recent Developments/Updates
Table 122. NCPC Competitive Strengths & Weaknesses
Table 123. Dynavax Basic Information, Manufacturing Base and Competitors
Table 124. Dynavax Major Business
Table 125. Dynavax Travelers Vaccines Product and Services
Table 126. Dynavax Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Dynavax Recent Developments/Updates
Table 128. Dynavax Competitive Strengths & Weaknesses
Table 129. AIM Vaccine Basic Information, Manufacturing Base and Competitors
Table 130. AIM Vaccine Major Business
Table 131. AIM Vaccine Travelers Vaccines Product and Services
Table 132. AIM Vaccine Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. AIM Vaccine Recent Developments/Updates
Table 134. AIM Vaccine Competitive Strengths & Weaknesses
Table 135. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 136. KM Biologics Major Business
Table 137. KM Biologics Travelers Vaccines Product and Services
Table 138. KM Biologics Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. KM Biologics Recent Developments/Updates
Table 140. KM Biologics Competitive Strengths & Weaknesses
Table 141. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 142. LG Life Sciences Major Business
Table 143. LG Life Sciences Travelers Vaccines Product and Services
Table 144. LG Life Sciences Travelers Vaccines Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. LG Life Sciences Recent Developments/Updates
Table 146. LG Life Sciences Competitive Strengths & Weaknesses
Table 147. Global Key Players of Travelers Vaccines Upstream (Raw Materials)
Table 148. Global Travelers Vaccines Typical Customers
Table 149. Travelers Vaccines Typical Distributors
LIST OF FIGURES
Figure 1. Travelers Vaccines Picture
Figure 2. World Travelers Vaccines Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Travelers Vaccines Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Travelers Vaccines Production (2021-2032) & (K Doses)
Figure 5. World Travelers Vaccines Average Price (2021-2032) & (USD/Dose)
Figure 6. World Travelers Vaccines Production Value Market Share by Region (2021-2032)
Figure 7. World Travelers Vaccines Production Market Share by Region (2021-2032)
Figure 8. North America Travelers Vaccines Production (2021-2032) & (K Doses)
Figure 9. Europe Travelers Vaccines Production (2021-2032) & (K Doses)
Figure 10. China Travelers Vaccines Production (2021-2032) & (K Doses)
Figure 11. Japan Travelers Vaccines Production (2021-2032) & (K Doses)
Figure 12. Travelers Vaccines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 15. World Travelers Vaccines Consumption Market Share by Region (2021-2032)
Figure 16. United States Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 17. China Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 18. Europe Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 19. Japan Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 20. South Korea Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 21. ASEAN Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 22. India Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 23. Producer Shipments of Travelers Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Travelers Vaccines Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Travelers Vaccines Markets in 2025
Figure 26. United States VS China: Travelers Vaccines Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Travelers Vaccines Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Travelers Vaccines Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Travelers Vaccines Production Market Share 2025
Figure 30. China Based Manufacturers Travelers Vaccines Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Travelers Vaccines Production Market Share 2025
Figure 32. World Travelers Vaccines Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Travelers Vaccines Production Value Market Share by Type in 2025
Figure 34. Meningococcal Vaccine
Figure 35. Japanese Encephalitis Vaccine
Figure 36. Yellow Fever Vaccine
Figure 37. Hepatitis Vaccine
Figure 38. Cholera Vaccine
Figure 39. Other
Figure 40. World Travelers Vaccines Production Market Share by Type (2021-2032)
Figure 41. World Travelers Vaccines Production Value Market Share by Type (2021-2032)
Figure 42. World Travelers Vaccines Average Price by Type (2021-2032) & (USD/Dose)
Figure 43. World Travelers Vaccines Production Value by Vaccination Purpose, (USD Million), 2021 & 2025 & 2032
Figure 44. World Travelers Vaccines Production Value Market Share by Vaccination Purpose in 2025
Figure 45. Mandatory Vaccination
Figure 46. Recommended Vaccination
Figure 47. Routine Booster
Figure 48. World Travelers Vaccines Production Market Share by Vaccination Purpose (2021-2032)
Figure 49. World Travelers Vaccines Production Value Market Share by Vaccination Purpose (2021-2032)
Figure 50. World Travelers Vaccines Average Price by Vaccination Purpose (2021-2032) & (USD/Dose)
Figure 51. World Travelers Vaccines Production Value by End Channel, (USD Million), 2021 & 2025 & 2032
Figure 52. World Travelers Vaccines Production Value Market Share by End Channel in 2025
Figure 53. Travel Clinics
Figure 54. Public Hospitals
Figure 55. Private Providers
Figure 56. World Travelers Vaccines Production Market Share by End Channel (2021-2032)
Figure 57. World Travelers Vaccines Production Value Market Share by End Channel (2021-2032)
Figure 58. World Travelers Vaccines Average Price by End Channel (2021-2032) & (USD/Dose)
Figure 59. World Travelers Vaccines Production Value by End Users, (USD Million), 2021 & 2025 & 2032
Figure 60. World Travelers Vaccines Production Value Market Share by End Users in 2025
Figure 61. Tourists
Figure 62. Students
Figure 63. Workers
Figure 64. Others
Figure 65. World Travelers Vaccines Production Market Share by End Users (2021-2032)
Figure 66. World Travelers Vaccines Production Value Market Share by End Users (2021-2032)
Figure 67. World Travelers Vaccines Average Price by End Users (2021-2032) & (USD/Dose)
Figure 68. Travelers Vaccines Industry Chain
Figure 69. Travelers Vaccines Procurement Model
Figure 70. Travelers Vaccines Sales Model
Figure 71. Travelers Vaccines Sales Channels, Direct Sales, and Distribution
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Travelers Vaccines Picture
Figure 2. World Travelers Vaccines Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Travelers Vaccines Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Travelers Vaccines Production (2021-2032) & (K Doses)
Figure 5. World Travelers Vaccines Average Price (2021-2032) & (USD/Dose)
Figure 6. World Travelers Vaccines Production Value Market Share by Region (2021-2032)
Figure 7. World Travelers Vaccines Production Market Share by Region (2021-2032)
Figure 8. North America Travelers Vaccines Production (2021-2032) & (K Doses)
Figure 9. Europe Travelers Vaccines Production (2021-2032) & (K Doses)
Figure 10. China Travelers Vaccines Production (2021-2032) & (K Doses)
Figure 11. Japan Travelers Vaccines Production (2021-2032) & (K Doses)
Figure 12. Travelers Vaccines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 15. World Travelers Vaccines Consumption Market Share by Region (2021-2032)
Figure 16. United States Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 17. China Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 18. Europe Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 19. Japan Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 20. South Korea Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 21. ASEAN Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 22. India Travelers Vaccines Consumption (2021-2032) & (K Doses)
Figure 23. Producer Shipments of Travelers Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Travelers Vaccines Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Travelers Vaccines Markets in 2025
Figure 26. United States VS China: Travelers Vaccines Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Travelers Vaccines Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Travelers Vaccines Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Travelers Vaccines Production Market Share 2025
Figure 30. China Based Manufacturers Travelers Vaccines Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Travelers Vaccines Production Market Share 2025
Figure 32. World Travelers Vaccines Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Travelers Vaccines Production Value Market Share by Type in 2025
Figure 34. Meningococcal Vaccine
Figure 35. Japanese Encephalitis Vaccine
Figure 36. Yellow Fever Vaccine
Figure 37. Hepatitis Vaccine
Figure 38. Cholera Vaccine
Figure 39. Other
Figure 40. World Travelers Vaccines Production Market Share by Type (2021-2032)
Figure 41. World Travelers Vaccines Production Value Market Share by Type (2021-2032)
Figure 42. World Travelers Vaccines Average Price by Type (2021-2032) & (USD/Dose)
Figure 43. World Travelers Vaccines Production Value by Vaccination Purpose, (USD Million), 2021 & 2025 & 2032
Figure 44. World Travelers Vaccines Production Value Market Share by Vaccination Purpose in 2025
Figure 45. Mandatory Vaccination
Figure 46. Recommended Vaccination
Figure 47. Routine Booster
Figure 48. World Travelers Vaccines Production Market Share by Vaccination Purpose (2021-2032)
Figure 49. World Travelers Vaccines Production Value Market Share by Vaccination Purpose (2021-2032)
Figure 50. World Travelers Vaccines Average Price by Vaccination Purpose (2021-2032) & (USD/Dose)
Figure 51. World Travelers Vaccines Production Value by End Channel, (USD Million), 2021 & 2025 & 2032
Figure 52. World Travelers Vaccines Production Value Market Share by End Channel in 2025
Figure 53. Travel Clinics
Figure 54. Public Hospitals
Figure 55. Private Providers
Figure 56. World Travelers Vaccines Production Market Share by End Channel (2021-2032)
Figure 57. World Travelers Vaccines Production Value Market Share by End Channel (2021-2032)
Figure 58. World Travelers Vaccines Average Price by End Channel (2021-2032) & (USD/Dose)
Figure 59. World Travelers Vaccines Production Value by End Users, (USD Million), 2021 & 2025 & 2032
Figure 60. World Travelers Vaccines Production Value Market Share by End Users in 2025
Figure 61. Tourists
Figure 62. Students
Figure 63. Workers
Figure 64. Others
Figure 65. World Travelers Vaccines Production Market Share by End Users (2021-2032)
Figure 66. World Travelers Vaccines Production Value Market Share by End Users (2021-2032)
Figure 67. World Travelers Vaccines Average Price by End Users (2021-2032) & (USD/Dose)
Figure 68. Travelers Vaccines Industry Chain
Figure 69. Travelers Vaccines Procurement Model
Figure 70. Travelers Vaccines Sales Model
Figure 71. Travelers Vaccines Sales Channels, Direct Sales, and Distribution
Figure 72. Methodology
Figure 73. Research Process and Data Source
